Femtech Market to Surpass $112 Billion by 2033
DataM Intelligence has released a new report projecting substantial growth for the global femtech market, forecasting a market value of $112.30 billion by 2033. This represents a significant increase from the $38.90 billion valuation recorded in 2024, with an anticipated compound annual growth rate (CAGR) of 12.6% during the forecast period extending from 2025 to 2033.
The report, which provides in-depth insights into market trends, growth opportunities, and challenges, highlights the increasing focus on technology-driven solutions for women’s healthcare. The term “femtech” (female technology) encompasses a range of digital health solutions and medical devices designed to address women’s specific health needs. These solutions span areas such as fertility, pregnancy, menopause, and menstrual care, demonstrating the sector’s wide-ranging scope.
A key driver for this growth is the growing adoption of innovative health solutions. Femtech innovations include period-tracking apps, wearable health monitors, and at-home diagnostic kits. These tools are providing women with personalized insights, data-driven information, and improved access to healthcare support. This trend is further fueled by increased awareness of women’s health issues and growing investment in female-specific health solutions.
Key Market Players
The report identifies several key players in the femtech market, including:
- Chiaro Technology Ltd.
- HeraMED
- Flo Health Inc.
- Allara Health
- Bloomlife
- Syrona Health
- Joylux, Inc.
- Coroflo Ltd.
- Bonzun
- Natural Cycles USA Corp
Industry Advancements
The report notes industry developments, such as the 2024 introduction of Ella, an AI assistant by PatientsLikeMe (PLM), designed to help women manage their health, powered by the generative AI platform Ema.
Regional Analysis and Market Segmentation
The femtech market analysis covers key regions globally, including North America, Europe, Asia-Pacific, the Middle East & Africa, and South America. These regions are further segmented to analyze specific trends and growth opportunities within each market. The report also segments the market by type (devices, software, services), application (women’s mental health, reproductive health, geriatric health, and oncology), and end-users (hospitals, diagnostic centers, fertility centers, and home care).
This press release provides a high-level overview of the DataM Intelligence report. The complete report offers a more detailed analysis of the market, offering businesses actionable intelligence to make informed decisions and capitalize on the evolving opportunities within the femtech sector.
